Classement en actions
#33382
Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as... Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as a global biopharmaceutical firm dedicated to the research, development, and marketing of cell-based pharmaceutical solutions. The company's core focus is on joint preservation and the regenerative repair of articular cartilage defects. Its offerings include Spherox, an advanced three-dimensional chondrocyte product specifically designed to address cartilage damage in adult knee joints. Additionally, co.don AG provides co.don chondrosphere, a therapy utilized for treating cartilage imperfections in younger patients across multiple joints, such as the hip, ankle, shoulder, elbow, and knees. These specialized treatments are primarily employed by orthopedic and trauma surgeons.
Prix de l'action
$0.29060802
Dernière synchronisation: 2022-09-30
Capitalisation boursière
$7.77M
Changement (1 jour)
-14.30%
Le prix CNW avec la capitalisation boursière de B
Capitalisation boursière de Co.don AG(CNW)
Capitalisation boursière: $7.77M
En August 2026, Co.don AG a une capitalisation boursière de $7.77M. Cela fait de Co.don AG la 33382nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Co.don AG du 2001 au 2026
CNW par rapport au top 5 des plus populaires stocks
| Prix pour CNW |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.452T
|
+70,198,697.41%
|
|
|
|
|
$4.490T
|
+57,813,851.41%
|
|
|
|
|
$4.162T
|
+53,595,471.52%
|
|
|
|
|
$3.676T
|
+47,336,855.10%
|
|
|
|
|
$2.833T
|
+36,478,441.86%
|
